A newly developed yoga program designed specifically to improve mobility and mental well-being for people in the early stages of Parkinson’s disease is heading to a clinical trial. Developed by a trio of scientists, the customized program was recently detailed in the journal Annals of Neurosciences, under the article…

When most people hear the words “Parkinson’s disease,” typically the first thing that comes to mind is tremors. Before my husband was diagnosed, I had the misconception that a person with Parkinson’s was always a cute older man with thinning gray hair and a shaky hand. For my husband,…

An investigational stem cell-based therapy that would replace the nerve cells, or neurons, lost due to Parkinson’s disease was found to be generally safe and feasible for use after one year of study in a first-in-human clinical trial — results the researchers say support the treatment’s continued clinical development.

Kenai Therapeutics has completed patient enrollment in a small, early clinical trial testing the safety and effectiveness of RNDP-001, its direct-to-the-brain cell therapy for treating an underlying cause of Parkinson’s disease. The Phase 1b/2a REPLACE trial (NCT07106021), now underway at three sites in the U.S., has recruited…

National Football League players had nearly four times the expected mortality rate from neurodegenerative diseases, including Parkinson’s disease, despite having lower overall mortality than the general population, a large study found. Researchers at Mass General Brigham, Boston University, and the Concussion & CTE Foundation conducted the study, which included nearly…